Australia markets closed

Arcus Biosciences, Inc. (RCUS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
15.70+0.20 (+1.29%)
At close: 04:00PM EDT
15.70 0.00 (0.00%)
After hours: 04:25PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts991010
Avg. Estimate-0.95-0.62-3.59-4.2
Low estimate-1.21-1.26-4.92-5.99
High estimate-0.422.21-1.28-2.41
Year ago EPS-1.09-1.04-4.15-3.59
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts881010
Avg. Estimate33.86M28.74M181.29M166.75M
Low estimate22M22M88M90M
High estimate72.5M40M502.19M524.84M
Year ago sales25M30.3M117M181.29M
Sales growth (year/est)35.40%-5.10%54.90%-8.00%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.16-1.1-1.13-1.02
Actual EPS-1.09-1.04-0.94-1.08
Difference0.070.060.19-0.06
Surprise %6.00%5.50%16.80%-5.90%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.95-0.62-3.59-4.2
7 days ago-0.93-0.57-3.48-4.24
30 days ago-0.94-0.58-3.52-4.27
60 days ago-0.9-0.48-3.28-4.21
90 days ago-1.03-1.16-3.73-4.36
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/A1N/AN/A
Up last 30 days1211
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1N/A11
Growth estimatesRCUSIndustrySector(s)S&P 500
Current qtr.12.80%N/AN/AN/A
Next qtr.40.40%N/AN/AN/A
Current year13.50%N/AN/AN/A
Next year-17.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A